Nitric Oxide-Generating Adherent Coating for Biomedical Devices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current NO-releasing materials for biomedical devices face challenges such as short half-life and uncertain safety doses, leading to inadequate long-term NO release, which limits their commercial use in applications like vascular stents and artificial blood vessels.

Innovation Solution

A nitric oxide-generating adherent coating is developed using polyphenol compounds, organic selenium or sulfur compounds, and soluble copper salts, which form a stable and controllable NO release coating through chemical coupling and molecular self-assembly, allowing firm adhesion to various materials and prolonged NO release.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If conventional NO-releasing materials are used, then initial NO release is achieved, but the release duration is too short for long-term implantation

Engineering Contradiction:
ImproveNO release durationVSAvoidlong-term stability
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The patent applies preliminary action by pre-coating the medical device surface with GPx-like catalytically active molecules before implantation. This pre-prepared coating system is designed to continuously catalyze RSNO decomposition into NO over extended periods, solving the short duration problem of conventional NO-releasing materials while maintaining long-term stability through the stable enzyme-matrix structure.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs composite materials by creating a coating system that integrates GPx-like catalytically active molecules (organic selenium or sulfur compounds) within a stable matrix material. This composite structure combines the catalytic activity for continuous NO generation with the structural stability needed for long-term implantation, resolving both duration and reliability requirements.

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If GPx-like catalytically active molecules are grafted onto material surface, then NO generation capability is achieved, but grafting amount is insufficient due to lack of functional groups

Engineering Contradiction:
ImproveGPx-like molecule grafting amountVSAvoidsurface functionalization difficulty
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by modifying the surface properties of the medical device through a coating process that enables high-density grafting of GPx-like molecules. By changing the surface parameters (creating a coating layer with appropriate physical and chemical properties), the system achieves sufficient grafting amounts without requiring complex pre-functionalization of the base material, thus solving both the quantity and manufacturing ease problems.

Inventive Principle:
Principle #35Parameter changes

3Duration of action of stationary object

If NO-releasing materials are used for long-term implantation, then continuous NO delivery is required, but current materials have uncertain safety doses limiting commercial use

Engineering Contradiction:
Improvelong-term NO deliveryVSAvoiduncertain safety dose
Core Design Contradiction:
Duration of action of stationary objectVSObject-affected harmful factors

Solution Approach 1:

The patent applies self-service by creating a coating system that automatically regulates NO production through the catalytic decomposition of endogenous RSNO substrates present in blood. The GPx-like catalytically active molecules continuously convert available RSNO into NO without requiring external dosing or complex delivery mechanisms, providing long-term safe NO delivery that adapts to physiological conditions and eliminates uncertain safety dose issues.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The coating ensures stable, long-term, and controllable NO release, enhancing blood compatibility, antimicrobial properties, and osteoinductive effects, suitable for biomedical devices and materials, including vascular stents and dental implants.

Implementation Method 1

Organic selenium compounds such as selenocystamine (SeCA) and 3,3'-diselenodipropionic acid (SeDPA), and organic sulfur compounds such as cystamine and cysteine have GPx-like activity to catalyze RSNO decomposition for NO production

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

A nitric oxide-generating adherent coating is developed using polyphenol compounds, organic selenium or sulfur compounds, and soluble copper salts, which form a stable and controllable NO release coating through chemical coupling and molecular self-assembly

Methodology Applied
Scientific EffectChemical bonding: Chemical Bonding

Implementation Method 3

A nitric oxide-generating adherent coating is developed using polyphenol compounds, organic selenium or sulfur compounds, and soluble copper salts, which form a stable and controllable NO release coating through chemical coupling and molecular self-assembly

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 4

A nitric oxide-generating adherent coating is developed using polyphenol compounds, organic selenium or sulfur compounds, and soluble copper salts, which form a stable and controllable NO release coating through chemical coupling and molecular self-assembly, allowing firm adhesion to various materials

Methodology Applied
Scientific EffectAdhesion: Adhesive

Data Source

PatentUS10736996B2Method for constructing nitric oxide-generating adherent coating
Publication Date: 2020.08.11 GUANGZHOU NANCHUANG EVEREST MEDICAL TECH CO LTD

AI summary

Disclosed is a method for preparing a nitric oxide-generating adherent coating, comprising: preparing a buffer solution containing polyphenol compounds, organic selenium or sulfur compounds and soluble copper salts; then contacting a base material with the solution, and washing and drying to obtain a target product. The nitric oxide-generating material prepared by the method can be used for any medical device, such as an intravascular stent, or materials and any complex-shaped base material, and has the capability of scavenging free radicals and catalyzing RSNO to produce nitrogen monoxide, and also has a response function of reduced glutathione (GSH), an antimicrobial function and all the physiological functions possessed by nitrogen monoxide.